Retinal Vasculitis Secondary to Durvalumab

Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, t...

Descripción completa

Detalles Bibliográficos
Autores principales: R. Andrade, Antonio, Moll-Udina, Aina, Martin, Ruth, Cilveti, Esther, Subirà, Olaia, Disfetano, Laura, García-Arumí, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250381/
https://www.ncbi.nlm.nih.gov/pubmed/32508622
http://dx.doi.org/10.1159/000507609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250381/
https://www.ncbi.nlm.nih.gov/pubmed/32508622
http://dx.doi.org/10.1159/000507609

Ejemplares similares